Share

April 2016; 6 (2) Commentary

Patient engagement and shared decision-making

What do they look like in neurology practice?

Melissa J. Armstrong, Lisa M. Shulman, Joseph Vandigo, C. Daniel Mullins
First published March 16, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000240
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
466

Share

Article Information

vol. 6 no. 2 190-197
DOI: 
https://doi.org/10.1212/CPJ.0000000000000240
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received December 7, 2015
  • Accepted January 12, 2016
  • First Published March 16, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Melissa J. Armstrong, MD, MSc,
    2. Lisa M. Shulman, MD,
    3. Joseph Vandigo, MBA and
    4. C. Daniel Mullins, PhD
  1. Melissa J. Armstrong, MD, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) International Parkinson and Movement Disorder Society, speaker honoraria for the 18th International Congresses (2014) (2) American Academy of Neurology, faculty honoraria for the 2014 and 2015 annual meetings

    Editorial Boards:

    1. (1) Neurology, Level of Evidence Editorial Board, 2012- current

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Parkinson's Disease Improving Patient Care, Oxford University Press, 2014

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) American Academy of Neurology Evidence-Based Medicine Methodology Consultant

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Abbvie (2) Insightec

    Research Support, Government Entities:

    1. (1) ARHQ, 1K08HS024159-01, PI, 2015-2020 (2) NIH U01 AR057967-01, sub-investigator, 2014-2015

    Research Support, Academic Entities:

    1. (1) University of Maryland School of Medicine

    Research Support, Foundations and Societies:

    1. (1) Parkinson Study Group (2) Huntington Study Group (3) CHDI Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Lisa M. Shulman, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. AAN Neurology Now Patient Book Series, Editor-in-Chief, 2007-2016; Neurology Now Magazine, Advisory Board member, 2007-2016

    Patents:

    1. NONE

    Publishing Royalties:

    1. Parkinson's Disease: A Complete Guide for Patients and Families, Johns Hopkins University Press, 2000, 2007, 2013

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Kyowa Pharmaceuticals, 2) Biotie

    Research Support, Government Entities:

    1. NIH U01AR057967-01, PI, 2009-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Michael J. Fox Foundation for Parkinsons Research, 2) The Rosalyn Newman Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Joseph Vandigo, MBA and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) AHRQ, R36HS022387-01A1, Principal Investigator, 2014-2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. C. Daniel Mullins, PhD
    5. Scientific Advisory Boards:

    1. Bayer, Mundipharma, Pfizer

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Bayer, Mundipharma, Pfizer

    Speakers' Bureaus:

    1. Pfizer

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Grants as PI from Bayer, Novartis, and Pfizer

    Research Support, Government Entities:

    1. Contracts and grants from AHRQ, NHLBI, and PCORI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Neurology (MJA), University of Florida College of Medicine, Gainesville; Department of Neurology (LMS), University of Maryland School of Medicine, Baltimore; and Pharmaceutical Health Services Research Department (JV, CDM), University of Maryland School of Pharmacy, Baltimore.
  1. Correspondence to:
    Melissa.Armstrong{at}neurology.ufl.edu
View Full Text

Article usage

Article usage: March 2016 to December 2022

AbstractFullPdfSource
Mar 201616525Highwire
Apr 2016303319Highwire
May 2016443312Highwire
Jun 201619911Highwire
Jul 20168503Highwire
Aug 20165914Highwire
Sep 20167507Highwire
Oct 201611902Highwire
Nov 20164301Highwire
Dec 20166304Highwire
Jan 20175400Highwire
Feb 20174002Highwire
Mar 20175113Highwire
Apr 20177613Highwire
Apr 2017798pmc
May 20173001Highwire
May 201781411pmc
Jun 20173800Highwire
Jun 2017277pmc
Jul 20173403Highwire
Jul 2017267pmc
Aug 20172531Highwire
Aug 2017278pmc
Sep 20172302Highwire
Sep 201721213pmc
Oct 20173811Highwire
Oct 201761619pmc
Nov 20173102Highwire
Nov 201761817pmc
Dec 20171900Highwire
Jan 20182960Highwire
Feb 20183060Highwire
Mar 20182031Highwire
Apr 20182910Highwire
Apr 201855565pmc
May 20183511Highwire
Jun 20182742Highwire
Jun 2018136472pmc
Jul 20183832Highwire
Aug 20182322Highwire
Aug 201888690pmc
Sep 20184042Highwire
Oct 20185033Highwire
Nov 20184833Highwire
Dec 20188241Highwire
Jan 20195842Highwire
Feb 20196813Highwire
Mar 20195831Highwire
Apr 20196512Highwire
May 20196041Highwire
Jun 20193720Highwire
Jul 20193301Highwire
Aug 20192710Highwire
Sep 20192865Highwire
Oct 20194021Highwire
Nov 20194630Highwire
Dec 20194120Highwire
Jan 20203910Highwire
Feb 20205282Highwire
Mar 20204735Highwire
Apr 20201502Highwire
May 20202300Highwire
Jun 20203300Highwire
Jul 20203510Highwire
Aug 20203011Highwire
Sep 20202713Highwire
Oct 20204400Highwire
Nov 20204612Highwire
Dec 20203020Highwire
Jan 20213531Highwire
Feb 20213420Highwire
Mar 20213811Highwire
Apr 20216423Highwire
May 20213410Highwire
Jun 20214820Highwire
Jul 20215952Highwire
Aug 20217731Highwire
Sep 20214530Highwire
Oct 20214720Highwire
Nov 20212900Highwire
Dec 20212900Highwire
Jan 20223510Highwire
Feb 20226012Highwire
Mar 20225012Highwire
Apr 20225010Highwire
May 20227210Highwire
Jun 20225511Highwire
Jul 202213801Highwire
Aug 202221707Highwire
Sep 202214581Highwire
Oct 20224231Highwire
Nov 20227692Highwire
Dec 20222420Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me